NCT03586570View on ClinicalTrials.gov

A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

September 10, 2018

Study Completion Date

September 10, 2018

Conditions
Healthy Subjects
Interventions
DRUG

Aprocitentan 25mg

Oral tablets in strength of 25 mg

DRUG

Placebo

Oral tablets matching aprocitentan tablets

Trial Locations (1)

92801

Anaheim Clinical Trials, Anaheim

Sponsors

Collaborators (1)

Janssen Biotech, Inc.
All Listed Sponsors
collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY